Chung Ang University Hospital

Seoul, Seoul Teugbyeolsi 6973

0 studies enrolling now · 1 studies all time

What they study most

Gastric, or Gastroesophageal Junction Adenocarcinoma

Studies at this site

• Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma — Completed